Desentum
Kati Sallinen has extensive experience in customer service, marketing, and communications roles in various companies such as City-Lab Oy, Thermo Fisher Scientific, Desentum Oy, University of Helsinki, and Finnzymes Oy. Kati has worked in areas such as global marketing, genetic engineering, market intelligence, and online communications. Currently, Kati holds a position as Director of Strategy & Communications at Desentum Oy.
This person is not in any teams
Desentum
Desentum is a biotechnology company in Finland developing an allergy vaccine that harnesses the immune system.